Conversations with commercial payers about reimbursement mechanisms is a next step, says researcher Kathi Mooney.
Women who get genetic testing for hereditary breast and ovarian cancer are often advised to talk to a genetic counselor before and after they take the test, even if the result is negative for a mutation that would indicate a greater risk.
Flatiron Health’s Dr. Bobby Green Outlines Novel Clinical Trial to Understand Genomic Changes in Tumors (VIDEO)
During the American Society of Clinical Oncology 2020 Annual Meeting, Flatiron Health, Foundation Medicine, and Genentech will be presenting plans for the Prospective Clinico-Genomic study (PCG), a low-interventional pilot that will use a technology-enabled prospective data collection platform to simplify data collection for patients with lung cancer being treated through clinical trials. The idea is collect blood samples using Foundation Medicine’s liquid biopsy assay and analyze the results through Flatiron’s platform, to see if genomic changes can be detected over the course of cancer treatment. Bobby Green, MD, chief medical officer for Flatiron Health, spoke with Managed Healthcare Executive®.
Ten of thousands of oncologists flock to the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago every year to hear about new drugs. Even preliminary or incremental developments can excite the crowd.
ASCO Report: Hydroxychloroiquine, Azithromycin Combo Associated With Mortality Risk Among Cancer Patients
Researchers caution, though, that the association may be of uncertain validity because of residual confounding.
Managed Healthcare Executive recently had a wide-ranging conversation with de Brantes about COVID-19, the healthcare sector and how the precipitious drops in utilization and provider revenue may affect the future of bundled payment and other alternative payment models.
Minnesota health insurance executive shares his belief that healthcare utilization peaks and valleys because of COVID-19, with MHE Senior Editor Peter Wehrwein.
The meteoric rise of telehealth amid the COVID-19 outbreak was recognized and possibly given an added boost by the rule for the 2021 Medicare Advantage contract year issued by CMS today.
AHA QCOR: Medicaid Expansion Associated With Improved Heart Failure Prescribing for Hispanic Patients
Evidence that Medicaid expansion improves healthcare delivery and outcomes continues to accumulate.
But recent Mathematica evaluation of CMS' Million Hearts program shows no cost saving